Conjunctival Provocation Test Grass-Mix LETI 30 HEP/ml
Sponsors
LETI Pharma S.L.U.
Conditions
Allergic rhinoconjunctivitis with or without asthma due to clinically relevant sensitisation to grass and olive pollen.Allergic rhinoconjunctivitis with or without controlled asthma
Phase 3
Clinical trial to evaluate the efficacy and safety of Depigoid DUO Grass-Mix/Olea (1000 DPP/mL + 1000 DPP/mL) compared with placebo in patients suffering from allergic rhinoconjunctivitis with or without asthma due to clinically relevant sensitisation to grass and olive pollen.
Not yet recruitingCTIS2025-521709-42-00
Target: 343Updated: 2026-03-25
Clinical trial to evaluate the efficacy and safety of two concentrations (1000DPP/ml and 3000DPP/ml) of depigmented polymerized allergen extracts of Depigoid GrassMix / Depigoid FORTE GrassMix compared to placebo, in patients suffering from allergic rhinoconjunctivitis with or without controlled asthma due to clinically relevant sensitization to grass pollen
Not yet recruitingCTIS2025-521736-10-00
Target: 324Updated: 2026-03-25